510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K162227Substantially Equivalent

STA® - Liatest® D-Di

Diagnostica Stago, Inc., Asnieres Sur Seine, FR / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K162227 is the FDA 510(k) clearance record for STA® - Liatest® D-Di, a class II device, cleared for Diagnostica Stago on under FDA product code DAP (Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control). FDA records list 19 510(k) clearances for Diagnostica Stago, from to . As of , FDA records show 2 recalls naming K162227.

Clearance record

Decision date
Received
(124 days to decision)
Product code
DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control
Regulation
21 CFR 864.7320
Device class
Class II
Review panel
Hematology
Applicant
Diagnostica Stago 3 Allee Theresa, Asnieres Sur Seine, FR
510(k) summary
Summary PDF
Third party review
No

Clearances, product code DAP

Trailing 12 months
1 clearance under product code DAP in the twelve months to October 2026, August 2026 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code DAP, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20261
September 20260
October 20260